



Remote ischemic preconditioning (RIPC) is a promising strategy for protecting against ischemic 
reperfusion injury. This study is a secondary analysis of a randomized study aimed to evaluate the 
effect of RIPC on the early increase in serum creatinine (SCr) following percutaneous coronary 
intervention (PCI) which is associated with contrast-induced acute kidney injury. Patients with 
stable angina undergoing elective PCI were assigned to control, RIPC, and continuous infusion of 
nicorandil groups. The endpoint of this study was the incidence of the early increase in SCr, a 
predictor of contrast-induced acute kidney injury, which was defined as either a > 20% or 
absolute increase by 0.3 mg/dl of SCr levels after 24 hours of PCI. This study included 220 
patients in whom a dataset of SCr values was available. The incidence of the early increase in 
SCr was significantly lower in the RIPC than in the Control (1.3% vs 10.8%, p = 0.03), but was 
not significantly different between the Nicorandil and the Control. In multivariate analysis, RIPC 
remained a significant factor associated with a reduction in the incidence of early increase in SCr. 
RIPC reduces the incidence of early increase in SCr in patients with stable angina following 
elective PCI. 
 
